CureMatch Articles & News
SAN DIEGO, CA – July 22, 2019 – CureMatch is pleased to announce the hire of Yekaterina Khotskaya as vice president of clinical operations. As head of CureMatch’s clinical operations, Dr. Khotskaya will bring her experience in research, software development, project management, and molecular diagnostics to work hand in hand with clinicians to bring CureMatch’s […]
SAN DIEGO, CA—June 26, 2019—CureMatch is pleased to announce two new hires. Katie Breitenbach has joined the AI-driven oncology treatment analysis company as chief financial officer; Viktor Novy has joined as chief technical officer. “Katie and Viktor are extremely well-regarded leaders, and a great fit for CureMatch,” said CureMatch CEO Bob Manning. “I am confident […]
Gratifying progress has been made recently in an emerging area of cancer medicine called precision oncology. It’s a bold attempt to target treatment to the very genes and molecules driving a cancer, aiming to slow or even halt its growth. But there’s always more to learn. Now comes evidence that, while a single well-matched drug […]
CureMatch’s co-founder and Chief Science Officer, Dr. Igor Tsigelny contributed to recently published cancer research concerning impact of viruses HTLV-1 and BLV on development of various cancers which could prove helpful to future CureMatch work. Findings are hopeful that it may be possible to eradicate these viruses acceleration of various cancers. The human T-cell leukemia […]
San Diego, CA (USA), Paris (France), – WeHealth by Servier, Servier Group’s e-health department, and CureMatch, a leader in digital health precision medicine announce a partnership to jointly bring the CureMatch digital platform to oncologists, clinics and hospitals around the world. We’ve been working with oncologists closely the past few years and understand they face a […]